Home » Topics » Regulatory » Patents

Patents
RSS

New heterocyclic bradykinin antagonists from Fujisawa

Jan. 26, 1998

Virus-host cell fusion inhibitors under study at Lilly

Jan. 26, 1998

Imidazoles for reversing MDR prepared at Ontogen

Jan. 26, 1998

Dual 5-HT reuptake inhibitors/5-HT1A antagonists developed at Lilly

Jan. 26, 1998

Squalene synthase inhibitors patented by Pfizer

Jan. 26, 1998

SS Pharm. describes new triazoles with oral activity

Jan. 26, 1998

Laminin-related polypeptides from the University of Minnesota

Jan. 26, 1998

Ontogen describes novel MDR modulators

Jan. 23, 1998

Merck & Co. describes FPTase inhibitors with improved pharmacokinetics

Jan. 23, 1998

TNF-alpha inhibitors disclosed by Celgene

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...